Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and

M Lodén1, N H Nielsen, G Roos

  • 1Department of Pathology, Umeå University, Sweden.

Oncogene
|June 3, 1999
PubMed

Insights

Breast cancer cell cycle deregulation involves cyclin E kinase activity. Inhibitory proteins p27 and p21 modulate this activity, impacting retinoblastoma protein phosphorylation and proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cell cycle regulation is crucial for preventing cancer.
  • Deregulation of G1-S phase transition, involving cyclin-dependent kinases, is common in tumors.
  • Enhanced cyclin-dependent kinase activity is hypothesized to drive cell cycle aberrations, but direct evidence in primary tumors is limited.

Purpose of the Study:

  • To determine cyclin E-dependent kinase activity (cyclin E(kinase)) in primary breast cancers.
  • To investigate the relationship between cyclin E(kinase), cyclin E expression, and levels of p27 and p21.
  • To assess the association of cyclin E(kinase) with retinoblastoma protein (pRb) phosphorylation and tumor proliferation.

Main Methods:

  • H1-kinase assay to measure cyclin E(kinase) in 59 primary breast cancer samples.
  • Analysis of cyclin E, p27, and p21 expression.
  • Assessment of in vivo pRb phosphorylation and proliferation markers in a subgroup of 48 tumors.

Main Results:

  • Cyclin E(kinase) positively correlated with cyclin E expression and inversely with p27 and p21 levels.
  • p27, but not p21, was linked to low cyclin E(kinase) at normal/low cyclin E levels.
  • High levels of both p21 and p27 were needed to suppress cyclin E(kinase) when cyclin E levels were elevated.
  • Cyclin E(kinase) correlated with pRb phosphorylation and proliferation, though pRb phosphorylation did not correlate with proliferation.
  • pRb phosphorylation was confirmed as a substrate for cyclin E(kinase) in primary breast cancer.

Conclusions:

  • Deregulation of cyclin E and p27 contributes to increased CDK-kinase activity in breast cancer.
  • While cyclin E and p27 influence kinase activity and pRb phosphorylation, other cyclin E-associated events may limit S-phase entry.
  • Findings highlight the complex interplay of cell cycle regulators in breast cancer progression.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.